Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method and kit for in vitro detecting responsiveness of epithelial tumor cells to therapeutic agent

A technology for in vitro detection of tumor cells, applied in cell culture active agents, tumor/cancer cells, biochemical equipment and methods, etc., can solve problems such as inability to quickly and effectively obtain accurate results of in vitro drug screening

Inactive Publication Date: 2018-05-11
BEIJING PERCANS ONCOLOGY CO LTD
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] In addition, due to the interference of normal cells in the in vitro reprogramming culture process and the limitations of the screening methods used in the currently used in vitro drug screening methods, it is often impossible to quickly and effectively obtain accurate results of in vitro drug screening.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and kit for in vitro detecting responsiveness of epithelial tumor cells to therapeutic agent
  • Method and kit for in vitro detecting responsiveness of epithelial tumor cells to therapeutic agent
  • Method and kit for in vitro detecting responsiveness of epithelial tumor cells to therapeutic agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0091] Isolation of CTOS and conditional reprogramming in single-cell cultures

[0092] After obtaining informed consent from the patients, tumor samples and normal samples from patients undergoing colorectal cancer surgery were obtained from Beijing Cancer Hospital.

[0093] First, non-tumor tissue and necrotic tissue are carefully stripped from the tumor sample. Cut the tumor tissue and normal tissue into small pieces with a diameter of less than 1 mm with scissors. Transfer the chopped tumor tissue and normal tissue to a 100 ml sterile conical glass bottle with a magnetic stirring bar. Add 0.25U / ml Liberase DH digestive enzyme (a certain proportion of collagenase I and collagenase, with neutral non-clostripain) to the shredded tissue ) and incubate at 37°C for 1-2 hours with gentle magnetic stirring.

[0094] The partially digested tumor cell clusters were first filtered through a 100-μm filter, and the filtrate was then filtered through a 40-μm filter. Tumor cell cl...

Embodiment 2

[0099] in vitro susceptibility testing

[0100] Following initial inoculation, drug testing was performed using dissociated tumor epithelial cells in a defined selective growth medium supplemented with nicotinamide and Y27632 (Rho-related helical coil containing protein kinase (ROCK-1) inhibitor) hESC SFM (defined, serum-free and feeder-free medium (SFM).

[0101] For ex vivo drug testing, inoculated tumor cells were exposed to the drug or drug combination for 72 hours. Drugs were prepared in DMSO and the final concentration of DMSO in the medium was 0.1%. Drugs and drug combinations were tested at ten-point serial dilutions (see Image 6 and related drawings). After drug exposure, tumor epithelial cells were labeled with 5-ethynyl-2'-deoxyuridine (Edu) to assess tumor cell proliferation rate. The labeling process lasted 24 hours with drug exposure. In the control group, epithelial cells did not receive drug exposure to media changes, but were similarly labeled with ...

Embodiment 3

[0105] Image Acquisition and Analysis

[0106] Stained tumor cells were imaged by a high-content screening (HCS) platform (Thermo Scientific Cellomics ArrayScan XTi HCSreader). Select a 10X objective lens to collect images, select 25 fields of view for each detection hole, and analyze a total of more than 3000 cells. The three fluorescent signals from the images were acquired from an HCS reader. The blue fluorescent signal records the signal of nuclei stained with Hoechst 33342; the green fluorescent signal detects Edu incorporated in newly synthesized DNA; the red fluorescent signal detects the EpCAM-positive epithelial cell population. Calculate the percentage of Edu-positive subpopulation cells in the total epithelial cells.

[0107] Such as Figures 7A-7B As shown in , for eight different patients, dose-response data were generated for Edu incorporation percentages for drugs and drug combinations, as well as quantitative drug susceptibility scores ( Figure 7B ). Da...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method and a kit for in vitro detecting the responsiveness of epithelial tumor cells to a therapeutic agent. The method and the kit are especially used for in vitro screening or medicine development of antitumor therapeutic agents.

Description

technical field [0001] The present invention relates to methods and kits for in vitro testing of the responsiveness of epithelial tumor cell cultures to therapeutic agents. The methods and kits of the present invention are particularly useful for in vitro screening of anti-tumor therapeutic agents. Background technique [0002] Despite continuous efforts to improve diagnosis and treatment, cancer remains the leading cause of death worldwide. The diversity or heterogeneity of cancers presents barriers to the development of new therapies and the identification of likely responders. In addition, many cancer treatments are challenged by primary and acquired resistance, including alternative pathways and additional point mutations that bypass the targets of therapeutic agents. [0003] Successful future therapeutic approaches may rely on comprehensive analysis of the events underlying tumor progression and metastatic processes, as well as the development of rapid and non-select...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/02
CPCC12N5/0693C12N2501/998C12N2502/1323G01N33/5011C12N2501/727
Inventor 张一洪杨振陈一友林艺海曹志翔
Owner BEIJING PERCANS ONCOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com